久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • VENCLEXTA Receives FDA Approval for AML americanpharmaceuticalreview
    October 22, 2020
    AbbVie announced the U.S. Food and Drug Administration (FDA) has provided full approval to VENCLEXTA? (venetoclax) in combination with azacitidine, or decitabine, or low-dose cytarabine (LDAC) for the treatment of newly-diagnosed acute myeloid leukemia ..
  • Pfizer gets EC approval for Daurismo to treat newly diagnosed acute myeloid leukaemia pharmaceutical-business-review
    July 02, 2020
    Pfizer has secured approval from the European Commission (EC) for its Daurismo (glasdegib) to treat certain adult patients with newly diagnosed acute myeloid leukaemia (AML).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service